Atlas Trials

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

Clinical trial NCT05478252 · COMPLETED

Trial details

NCT number
NCT05478252
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2022-08-03
Primary completion
2023-08-09
Enrollment
388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.